The EMA is conducting a joint screening of candidates for the Corona 19 vaccine developed by U.S. pharmaceutical company Pfizer-German

"Depending on how the assessment goes, 달토가라오케 the EMA may really be in a position to finish its assessment of the front-runner by the end of this year or early next year," the EMA added. The EMA is conducting a joint screening of candidates for the Corona 19 vaccine developed by U.S. pharmaceutical company Pfizer-German Bioentech, U.S. pharmaceutical company Moderna, and British Oxford University-multinational pharmaceutical company AstraZeneca. 클럽레이스 The companion screening is a procedure to expedite the evaluation of promising clinical trial drugs or vaccines in public health emergency situations such as the global trend of Corona19. Pfizer-Bioentech has already sent data to the EMA after announcing the final results of a three-phase clinical trial in which the immune effects of the Corona 19 vaccine developed by the two companies are 95 percent. More than 55 million Corona 19 confirmed cases worldwide, 클럽플렉스 with more than 1.3 million dead. Many people hope that vaccines can be a solution.